|Articles|November 1, 2017
- Pharmaceutical Executive-11-01-2017
- Volume 37
- Issue 11
Pharmaceutical Executive, November 2017 Issue (PDF)
Click the title above to open the Pharmaceutical Executive November 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharm Exec's 2018 Pipeline Reportover 8 years ago
Taiwan’s Biotech Boomover 8 years ago
The Fine Line of Pharma & Patient Group Collaborationover 8 years ago
FDA Explores Flexible Drug Marketing Policiesover 8 years ago
No Overnight Successesover 8 years ago
Aligning Early Advice with Long-Term Planningover 8 years ago
Navigating the Untapped NASH Marketover 8 years ago
Interpreting UK’s Post-Brexit Life Sciences Strategyover 8 years ago
When HIPAA Doesn’t Applyover 8 years ago
Country Report: AustriaAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
How Exposed is The U.S. Pharmaceutical Supply Chain to China’s Updated Export Control Regulations?
2
Why High-Risk Patients Still Need Antivirals: Q&A with Gurinder S. Sidhu, M.D.
3
Pharmaceutical Executive Daily: Bristol Myers Squibb Expands Partnership with Nvidia
4
A Patent Strategy Pharma Execs May Be Overlooking: Means-Plus-Function Claims
5